Current status and prospects of MOFs in controlled delivery of Pt anticancer drugs-Reference-Cited by-同舟云学术

Current status and prospects of MOFs in controlled delivery of Pt anticancer drugs

Published:2023 Issue:19 Volume:52 Page:6226-6238
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Chen Jinyi¹²,Zhang Zhixin²,Ma Jiaxin²,Nezamzadeh-Ejhieh Alireza³^ORCID,Lu Chengyu²,Pan Ying¹²,Liu Jianqiang¹²⁴^ORCID,Bai Zhi¹

Affiliation:

1. The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China

2. Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Guangdong Medical University Key Laboratory of Research and Development of New Medical Materials, Dongguan, 523808, China

3. Chemistry Department, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran

4. Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

Abstract

This review focuses on the application of platinum as an anticancer drug and the MOF materials loading platinum species; the prospect for its future development is also discussed.

Funder

National College Students Innovation and Entrepreneurship Training Program

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D3DT00413A

Reference120 articles.

1. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

2. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer